CSL PHARMA-ADVICE ApS: Financial statements 2020
CVR: 36501693
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
CSL PHARMA-ADVICE ApS (CVR 36501693) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 143,177 and a net result of DKK 70,715 compared with DKK 134,580 the year before. That is a decrease of 45.2% compared with the year before. The profit margin was 49.4%. Equity in the 2020 report amounted to DKK 420,914. The solvency ratio was 93.6%.
- Revenue
- DKK 143,177
- Gross Profit
- DKK 94,978
- Profit/Loss
- DKK 70,715
- Equity
- DKK 420,914
- Total Assets
- DKK 449,540
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 143 t. | 95 t. | 71 t. | 421 t. | - |
| 2019 | 261 t. | 181 t. | 135 t. | 480 t. | - |
| 2018 | 400 t. | 281 t. | 214 t. | 546 t. | - |
| 2017 | 404 t. | 337 t. | 262 t. | 571 t. | - |
| 2016 | 249 t. | 189 t. | 145 t. | 309 t. | - |
Official annual report
How creditworthy is CSL PHARMA-ADVICE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
CSL PHARMA-ADVICE ApS has published its annual report for 2019. Revenue came to DKK 261,334, and the net result was DKK 134,580.
About CSL PHARMA-ADVICE ApS
CSL PHARMA-ADVICE ApS was a Danish company of the type Anpartsselskab based in Lejre, founded in 2015. The company has been dissolved on 4 January 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. In 2022, the company reported a gross profit of DKK 30,604 and a net result of DKK 32,496 compared with DKK -44,528 the year before. Equity in the 2022 report amounted to DKK 133,890.